FDCFF yields 6849.32% · MRK yields 2.81%● Live data
📍 FDCFF pulled ahead of the other in Year 1
Combined, FDCFF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FDCFF + MRK for your $10,000?
Forum Energy Metals Corp. engages in the evaluation, acquisition, exploration, and development of natural resource properties in Canada and the United States. The company explores for energy metals, including copper, cobalt, uranium, palladium, nickel, platinum, and gold deposits. It holds 100% interests in the Fir Island uranium project covering an area of 20,463; the Janice Lake copper-silver project that covers an area of 39,943 hectares; the Love Lake nickel-copper-palladium-platinum project that covers an area of 32,135 hectares; the Grease River project covering an area of 10,528 hectares; the Wollaston project covering an area of 11,067 hectares; the Highlands project; the Glennie project; the Highrock uranium project; the Still Nickel project; and the Maurice Point uranium project that covers an area of 6,295 hectors located in Saskatchewan. It also holds a 65% interest in the Costigan uranium project; 75% interest in the Clearwater uranium project; 40% interest in the Henday uranium project; and 39.43% interest in the NW Athabasca located in Saskatchewan. In addition, the company also holds 100% interests in the Quartz Gulch property consist of 127 claims covering an area of 10.65 square kilometers located in Idaho; and 100% interests in the Nunavut Uranium project consist of 40 claims covering an area of 97,433 hectares located on the northeast of the Thelon Basin in Nunavut Territory. The company was formerly known as Forum Uranium Corp. and changed its name to Forum Energy Metals Corp. in February 2018. Forum Energy Metals Corp. was incorporated in 1987 and is headquartered in Vancouver, Canada.
Full FDCFF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.